Microbiome Company Announces Merger Agreement With Therapeutics Giant

BiomX Merges with Adaptive Phage Therapeutics, Secures $50 Million Financing.

Disclaimer: This post includes affiliate links. If you purchase anything through these affiliated links, the author/website may earn a commission. This article is purely informational and does not constitute financial advice.

In a significant development in the biotech sector, BiomX Inc. (NYSEAMERICAN: PHG), a clinical-stage microbiome company, has annou…